Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · December 21, 2024

Reduced DOAC Dose vs Dual Antiplatelet Therapy After Left Atrial Appendage Closure in Patients With Nonvalvular Atrial Fibrillation

Heart Rhythm

 

Additional Info

Disclosure statements are available on the authors' profiles:

Heart Rhythm
Reduced direct oral anticoagulant dose vs dual antiplatelet therapy after left atrial appendage closure in patients with nonvalvular atrial fibrillation: A systematic review and meta-analysis
Heart Rhythm 2024 Nov 22;[EPub Ahead of Print], NA Lima, FWPA Filho, BX Mendes, VLM Neto, ALB d'Avila

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading